Practice Areas: Defective Drugs

Do You Take Heartburn Medication?

The FDA ordered the popular heartburn drug Zantac and other manufacturers of prescription and over-the-counter ranitidine drugs to be pulled from the marketplace immediately. At issue: the contaminant N-Nitrosodimethylamine (NDMA). Found in some ranitidine products, NDMA levels were found to increase over time and when stored at higher room temperatures, exposing consumers to unacceptable levels […]

Read More

Are you taking Nizatidine or Ranitidine?

These medications may contain unacceptable levels of NDMA. Exposure to this compound can increase cancer risk as well as organ and bone marrow damage, tumors, and gene mutation. Last year the FDA posted recalls for these heartburn and stomach ulcer drugs due to NDMA contamination. In 2018 a blood pressure medication was recalled for over […]

Read More

FDA Investigating Diabetes Drug for Cancer-Causing Contaminant

Reports of low levels of Nitrosamine contamination, N-Nitrosodimethylamine (NDMA), in some Metformin products outside of the United States have prompted an investigation into the popular diabetes drug in the United States, according to the Food and Drug Administration (FDA).  Metformin is the most popular oral medication for prediabetes, insulin resistance and type 2 diabetes- worldwide. […]

Read More

Don’t Take a Chance if Your Car has Takata Airbags

Takata Airbags are defective and now there are MORE recalls you need to be aware of. A recent article in the Miami Herald says that there are over 900,000 vehicles in Florida with the defective airbags and 17 million in the U.S. How to See if Your Vehicle Has Takata Airbags Go to the National […]

Read More

Opioid Distributor’s Attorney States: No Obligation to the Public

Big Pharma is facing 2,000 lawsuits from state, local and tribal governments for its role in fueling America’s opioid epidemic which claimed nearly 48,000 lives in 2017 alone. According to an Associated Press story, an attorney for Cardinal Health, one of the country’s largest drug distribution companies, stated under questioning that  “the business has no obligation […]

Read More

Opioid Drug Maker Settles for $270 Million

Purdue Pharma, the maker of Oxycontin, and the Sackler family, founder and owner of Purdue Pharma, have agreed to settle a lawsuit brought by the Oklahoma attorney general for $270 million. OxyContin is an opioid painkiller that was falsely marketed as safe and less addictive. States across the nation are fighting an opioid epidemic that […]

Read More

Opioid Marketing Linked to Opioid Deaths

Nearly 48,000 people died from opioid overdoses in 2017 alone. That accounts for approximately 68% of all deaths due to overdose. A new study published in the JAMA Network Open directly links opioid marketing to the potential increase in prescription opioid deaths. The more money that was spent to market opioids to doctors, the more […]

Read More

We Are All Working for You!

Our firm recently celebrated Wayne Hogan receiving the American Association for Justice 2017 Lifetime Achievement Award. Our firm is like family and what matters at Terrell Hogan is that everyone here shares a passion for the mission to represent our clients as they seek justice. At Terrell, Hogan we’re surrounded by many of the brightest […]

Read More

FDA Warning Regarding Type2 Diabetes Drug Invokana

Two clinical trials of Type2 diabetics taking Johnson & Johnson’s diabetes drug, Invokana, also known also as canagliflozin, have revealed that users are twice as likely to suffer foot and leg amputations than those given a placebo. The U.S. Food and Drug Administration is requiring Johnson & Johnson to add new warnings about the risk […]

Read More

Generic Drugs: Possibly a Worse Deal than We Thought

As we have reported in previous articles, the U.S. Supreme Court’s 2011 ruling in Pliva v. Mensing left patients taking generic drugs with virtually no remedies when they are harmed or killed by defectively designed generic drugs.  The irony of the ruling was that in 2008 the Supreme Court ruled in Wyeth v. Levine that […]

Read More